LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Longer-term results showed that treated patients developed fewer liver-related adverse effects and improved survival compared to the control group.
“as longer-term results showed that treated patients developed fewer liver-related adverse effects and improved survival compared to the control group, suggesting potential clinical benefits (180, 181).”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [180]
Cited by
Sorted by citations
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03406-8 · Cited by 66 · see citing works
Self-citationTargeting macrophages in liver fibrosis
González del Barrio, L., Ipsen, D. H., Pfister, D. R., Hancz, D., & Scott, C. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835489 · Cited by 3 · see citing works
- Authors
- Brennan, P., Macpherson, I., Troland, D., Kilpatrick, A. M., Manship, T., McGowan, N., Campbell, J., Fraser, A., Pass, C., Moroni, F., Morris, D., Glover, A., Semple, S., MacMillan, M., Graham, C., Turner, M., Dillon, J. F., Lachlan, N., Fallowfield, J., & Forbes, S. J.
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2024-06
- Volume
- 80
- Pages
- S81
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4399458404
- Cited by
- 3
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Keywords
- macrophage transplantation, compensated cirrhosis, liver cirrhosis, clinical outcomes, long-term follow-up
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review